NO20022276L - Placental human neurokinin-B-forlöper - Google Patents
Placental human neurokinin-B-forlöperInfo
- Publication number
- NO20022276L NO20022276L NO20022276A NO20022276A NO20022276L NO 20022276 L NO20022276 L NO 20022276L NO 20022276 A NO20022276 A NO 20022276A NO 20022276 A NO20022276 A NO 20022276A NO 20022276 L NO20022276 L NO 20022276L
- Authority
- NO
- Norway
- Prior art keywords
- precursor
- methods
- human neurokinin
- neurokinin
- placental human
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Pregnancy & Childbirth (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9927125.6A GB9927125D0 (en) | 1999-11-16 | 1999-11-16 | Placental human neurokinin B precursor |
PCT/GB2000/004315 WO2001036979A2 (en) | 1999-11-16 | 2000-11-10 | Placental human neurokinin b precursor |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20022276D0 NO20022276D0 (no) | 2002-05-14 |
NO20022276L true NO20022276L (no) | 2002-07-05 |
NO330412B1 NO330412B1 (no) | 2011-04-11 |
Family
ID=10864633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20022276A NO330412B1 (no) | 1999-11-16 | 2002-05-14 | Fremgangsmate for forutsigelse eller diagnostisering av graviditetsindusert hypertension, diagnostisk sett, og anvendelse av middel som hemmer biologisk effekt av neurokinin B |
Country Status (15)
Country | Link |
---|---|
US (1) | US7947458B1 (no) |
EP (1) | EP1229965B1 (no) |
JP (1) | JP4668501B2 (no) |
CN (1) | CN1414871A (no) |
AT (1) | ATE299739T1 (no) |
AU (1) | AU778423B2 (no) |
CA (1) | CA2391531A1 (no) |
DE (1) | DE60021409T2 (no) |
ES (1) | ES2244480T3 (no) |
GB (1) | GB9927125D0 (no) |
IL (1) | IL149598A0 (no) |
NO (1) | NO330412B1 (no) |
NZ (1) | NZ519283A (no) |
WO (1) | WO2001036979A2 (no) |
ZA (1) | ZA200203880B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6919433B2 (en) | 1997-03-14 | 2005-07-19 | Human Genome Sciences, Inc. | Antibodies to protein HPMBQ91 |
EP1333092A3 (en) * | 1997-03-14 | 2003-12-10 | Human Genome Sciences, Inc. | 28 human secreted proteins |
WO2023278843A2 (en) | 2021-07-02 | 2023-01-05 | Acer Therapeutics, Inc. | Solid forms of osanetant |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4665157A (en) | 1985-09-30 | 1987-05-12 | Mcneilab, Inc. | Peptide antagonists of neurokinin B |
US4742156A (en) * | 1985-09-30 | 1988-05-03 | Mcneilab, Inc. | Peptide antagonists of neurokinin B and opthalmic solutions containing them |
US5331089A (en) | 1988-03-25 | 1994-07-19 | Merck Sharpe & Dohme, Ltd. | Peptides useful as tachykinin agonists |
US5079171A (en) * | 1988-09-15 | 1992-01-07 | Adeza Biomedical Corporation | Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin |
PT533280E (pt) | 1991-09-20 | 2001-01-31 | Glaxo Group Ltd | Novas utilizacoes medicas para antagonistas de taquiquinina |
US5328927A (en) | 1992-03-03 | 1994-07-12 | Merck Sharpe & Dohme, Ltd. | Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
AU4713293A (en) | 1992-07-13 | 1994-01-31 | Merck Sharp & Dohme Limited | Heterocyclic amide derivatives as tachykinin derivatives |
NZ255721A (en) | 1992-08-13 | 1997-06-24 | Warner Lambert Co | Hetarylmethoxy carbonyl substituted tryptophan amides, esters, analogues and pharmaceutical compositions thereof |
US5922681A (en) * | 1992-09-14 | 1999-07-13 | Warner-Lambert Company | Endothelin antagonists |
FR2696178B1 (fr) | 1992-09-30 | 1994-12-30 | Sanofi Elf | Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant. |
US5344830A (en) | 1992-12-10 | 1994-09-06 | Merck & Co., Inc. | N,N-diacylpiperazine tachykinin antagonists |
US5543138A (en) * | 1994-03-10 | 1996-08-06 | Genetics Institute, Inc. | Methods of diagnosing and treating preeclampsia |
FR2719311B1 (fr) * | 1994-03-18 | 1998-06-26 | Sanofi Sa | Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. |
US5491140A (en) | 1994-06-30 | 1996-02-13 | Eli Lilly And Company | Naphthyl tachykinin receptor antagonists to treat physiological conditions |
PL180866B1 (pl) | 1994-07-12 | 2001-04-30 | Lilly Co Eli | Nowy trihydrat dichlorowodorku (R)-3-(1H-indol-3-ilo)-1-[N-(2-metoksybenzylo)acetyloamino]-2-[N-(2-(4-(piperydyn-1-ylo)piperydyn-1-ylo)acetylo)amino]propanu |
CA2154116A1 (en) | 1994-07-22 | 1996-01-23 | Philip Arthur Hipskind | 1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists |
JP2000511193A (ja) * | 1996-05-24 | 2000-08-29 | イーライ・リリー・アンド・カンパニー | 高血圧の処置法 |
GB9618931D0 (en) * | 1996-09-11 | 1996-10-23 | Univ London | Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes |
US5846973A (en) | 1997-05-23 | 1998-12-08 | Eli Lilly And Company | Methods of treating pulmonary hypertension |
US5985606A (en) | 1997-06-19 | 1999-11-16 | Incyte Pharmaceuticals, Inc. | Human preprotachykinin B |
EP0892053A3 (en) * | 1997-07-14 | 1999-12-29 | Smithkline Beecham Plc | production of recombinant HPMBQ91 polypeptide and uses thereof |
CA2236489A1 (en) * | 1997-07-14 | 1999-01-14 | Human Genome Sciences | Novel compounds |
US6689566B1 (en) * | 1999-01-14 | 2004-02-10 | Scantibodies Laboratory, Inc. | Methods, kits, and antibodies for detecting parathyroid hormone |
-
1999
- 1999-11-16 GB GBGB9927125.6A patent/GB9927125D0/en not_active Ceased
-
2000
- 2000-11-10 DE DE60021409T patent/DE60021409T2/de not_active Expired - Lifetime
- 2000-11-10 NZ NZ519283A patent/NZ519283A/en not_active IP Right Cessation
- 2000-11-10 IL IL14959800A patent/IL149598A0/xx unknown
- 2000-11-10 ES ES00974680T patent/ES2244480T3/es not_active Expired - Lifetime
- 2000-11-10 CN CN00818115A patent/CN1414871A/zh active Pending
- 2000-11-10 EP EP00974680A patent/EP1229965B1/en not_active Expired - Lifetime
- 2000-11-10 CA CA002391531A patent/CA2391531A1/en not_active Abandoned
- 2000-11-10 AU AU12898/01A patent/AU778423B2/en not_active Ceased
- 2000-11-10 WO PCT/GB2000/004315 patent/WO2001036979A2/en active IP Right Grant
- 2000-11-10 US US10/130,340 patent/US7947458B1/en not_active Expired - Fee Related
- 2000-11-10 AT AT00974680T patent/ATE299739T1/de not_active IP Right Cessation
- 2000-11-10 JP JP2001538816A patent/JP4668501B2/ja not_active Expired - Fee Related
-
2002
- 2002-05-14 NO NO20022276A patent/NO330412B1/no not_active IP Right Cessation
- 2002-05-15 ZA ZA200203880A patent/ZA200203880B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1229965A2 (en) | 2002-08-14 |
NO20022276D0 (no) | 2002-05-14 |
JP4668501B2 (ja) | 2011-04-13 |
US7947458B1 (en) | 2011-05-24 |
CN1414871A (zh) | 2003-04-30 |
WO2001036979A3 (en) | 2002-05-02 |
NO330412B1 (no) | 2011-04-11 |
WO2001036979A2 (en) | 2001-05-25 |
ZA200203880B (en) | 2003-08-15 |
CA2391531A1 (en) | 2001-05-25 |
AU1289801A (en) | 2001-05-30 |
ATE299739T1 (de) | 2005-08-15 |
AU778423B2 (en) | 2004-12-02 |
DE60021409T2 (de) | 2006-05-24 |
EP1229965B1 (en) | 2005-07-20 |
JP2003515138A (ja) | 2003-04-22 |
ES2244480T3 (es) | 2005-12-16 |
DE60021409D1 (de) | 2005-08-25 |
NZ519283A (en) | 2004-05-28 |
GB9927125D0 (en) | 2000-01-12 |
IL149598A0 (en) | 2002-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200002731T2 (tr) | Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar | |
ATE364618T1 (de) | Antikörper gegen das muc18-antigen | |
IL127558A0 (en) | Hepatocyte growth factor receptor agonists and uses thereof | |
CY1112507T1 (el) | Μορια αντισωματος που εχουν ειδικοτητα για την ανθρωπινη ιl-1β | |
ATE320265T1 (de) | Staphylococcus-antigene und impstoff | |
BR0108711A (pt) | Expressão heteróloga de proteìnas de neisseria | |
ATE402192T1 (de) | Anti-ccr4 antikörper und fragmente davon | |
TR200002284T2 (tr) | Mage ailesinden tümör ile ilgili tümör türevleri | |
BRPI9912227B8 (pt) | método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método. | |
ATE197592T1 (de) | Monoklonaler antikörper gegen cd44v6 | |
EP1467757A4 (en) | USE OF ANTIBODIES TO THE MUC18 ANTIGEN | |
DE3750389D1 (de) | Antikörper gegen menschlichen progesteronrezeptor sowie diagnosematerial und -verfahren. | |
ECSP088636A (es) | Antígenos de ácido des-n-acetil-siálico, anticuerpos para los mismos, y métodos de uso en la terapia de cáncer | |
DK208987D0 (da) | Polypeptider og antistoffer, som er karakteristiske for papillomvirus, og deres anvendelse ved diagnostiske metoder og i vacciner | |
DE60113445D1 (de) | Substanzen mit verzweigten linkermolekülen | |
EP1572225A4 (en) | THROMBOSPONDIN FRAGMENTS AND THEIR USE IN CLINICAL CANCER TESTS AND THE PRODUCTION OF ANTIBODIES AND OTHER BINDING AGENTS | |
NO20022276L (no) | Placental human neurokinin-B-forlöper | |
ATE514780T1 (de) | Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon | |
IT1307864B1 (it) | Metodo diagnostico per il riconoscimento di neoplasie umane attraversola determinazione dell'isoforma ctn-c della tn-c, frammenti di | |
IL117151A0 (en) | Novel antigen | |
DE60222817D1 (de) | Lösliche komplexe von zielproteinen und peptidyl-prolyl-isomerase-chaperonen sowie deren herstellung und verwendung | |
CY1112424T1 (el) | Πυρηνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 238ρ1β2 χρησιμα στην αγωγη και ανιχνευση του καρκινου | |
ATE343596T1 (de) | Humane monoklonale antikörper gegen inselzellantigen ia-2 | |
ITRM20020568A1 (it) | Frammenti antigenici di toxoplasma gondii, metodo per il loro ottenimento, loro uso in kit diagnostici e per la preparazione di vaccini. | |
ITCT920022A1 (it) | Test immunoenzimatico competitivo per il rilievo quantitativo del frammento secretorio presente nel siero, nella saliva, nell'urina, nelle lacrime, nel succo gastrico, nel secreto vaginale, nelle feci. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |